These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4205522)

  • 1. A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils.
    Husby G; Natvig JB
    J Clin Invest; 1974 Apr; 53(4):1054-61. PubMed ID: 4205522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidosis in rheumatoid arthritis.
    Husby G
    Ann Clin Res; 1975 Jun; 7(3):154-67. PubMed ID: 1103711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
    Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
    Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA).
    Marhaug G; Sletten K; Husby G
    Clin Exp Immunol; 1982 Nov; 50(2):382-9. PubMed ID: 7151331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel amyloid fibril protein isolated from senescence-accelerated mice.
    Matsumura A; Higuchi K; Shimizu K; Hosokawa M; Hashimoto K; Yasuhira K; Takeda T
    Lab Invest; 1982 Sep; 47(3):270-5. PubMed ID: 6810021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the amyloid A protein (AA protein) and a related serum component-purification-partial characterization and tissue origin and distribution in different types of amyloidosis.
    Franklin EC; Rosenthal CJ; Pras M
    Adv Nephrol Necker Hosp; 1975; 5():89-97. PubMed ID: 811096
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.
    Linke RP; Sipe JD; Pollock PS; Ignaczak TF; Glenner GG
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1473-6. PubMed ID: 805429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "A" protein of amyloidosis. Isolation of a cross-reacting component from serum by affinity chromatography.
    Benson MD; Skinner M; Lian J; Cohen AS
    Arthritis Rheum; 1975; 18(4):315-22. PubMed ID: 50844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid P-component levels in amyloidosis, connective tissue diseases, infection, and malignancy as compared to normal serum.
    Skinner M; Vaitukaitis JL; Cohen AS; Benson MD
    J Lab Clin Med; 1979 Oct; 94(4):633-8. PubMed ID: 479670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-associated changes of an amyloid related serum component.
    Rosenthal CJ; Franklin EC
    Trans Assoc Am Physicians; 1974; 87():159-68. PubMed ID: 4456729
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative studies of the high molecular weight amyloid fibril proteins and similar components from normal tissues.
    Scott DL; Marhaug G; Husby G
    Clin Exp Immunol; 1983 Jun; 52(3):693-701. PubMed ID: 6409474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
    Pepys MB; Herbert J; Hutchinson WL; Tennent GA; Lachmann HJ; Gallimore JR; Lovat LB; Bartfai T; Alanine A; Hertel C; Hoffmann T; Jakob-Roetne R; Norcross RD; Kemp JA; Yamamura K; Suzuki M; Taylor GW; Murray S; Thompson D; Purvis A; Kolstoe S; Wood SP; Hawkins PN
    Nature; 2002 May; 417(6886):254-9. PubMed ID: 12015594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component.
    Levin M; Pras M; Franklin EC
    J Exp Med; 1973 Aug; 138(2):373-80. PubMed ID: 4198200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of a serum protein, C1t, to a common nonfibrillar constituent of amyloid (P component) as revealed by immunohistochemical studies.
    Katz A; Weicker-Thorne J; Painter RH
    Am J Pathol; 1977 Sep; 88(3):679-98. PubMed ID: 329683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amyloidosis. I. Recent findings concerning amyloid substance].
    Lovisetto P; Gilardi E; Frascisco M; Marchi L; Mairano D
    Minerva Med; 1980 Jun; 71(25):1793-800. PubMed ID: 6997780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New, third class of amyloid fibril protein.
    Husby G; Natvig JB; Sletten K
    J Exp Med; 1974 Mar; 139(3):773-8. PubMed ID: 4204730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid A in systemic amyloidosis associated with cancer.
    Husby G; Marhaug G; Sletten K
    Cancer Res; 1982 Apr; 42(4):1600-3. PubMed ID: 7060030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal amyloidosis in childhood. An overview of the topic with 25 years experience.
    Tinaztepe K
    Turk J Pediatr; 1995; 37(4):357-73. PubMed ID: 8560604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.